ACCC is seeking opinions on a divestment undertaking offered by Elanco pertaining to its proposed acquisition of Bayer Aktiengesellschaft’s animal health business.
The ACCC has initial competition concerns related to worming treatments frequently used for cats & dogs, as the acquisition would merge ownership of Elanco’s Milbemax and, Interceptor brands with Bayer’s Drontal, Profender and Droncit brands.
Other preliminary concern was related to the consolidation in sheep lice products.
The proposed divestment task would compel Elanco to sell the Drontal, Profender and Droncit worming brands, and the Avenge+Fly sheep lice brand to a buyer or buyers authorized by the ACCC.
The ACCC now seeks opinions from market participants on whether the planned undertaking would be likely to alleviate competition worries in sheep lice therapies, and intestinal worming treatments for companion animals.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.